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Purpose: Surgical treatment for prostate cancer represents a large national
health care expenditure. We determined whether state level variation in the cost
of radical prostatectomy exists and whether we could explain this variation by
adjusting for covariates associated with cost.
Materials and Methods: Using the 2004 Healthcare Cost and Utilization Project
National Inpatient Sample of 7,978,041 patients we identified 9,917 who were 40
years old or older with a diagnosis of prostate cancer who underwent radical
prostatectomy without cystectomy. We used linear regression to examine state
level regional variation in radical prostatectomy costs, controlling for the local
area wage index, patient demographics, case mix and hospital characteristics.
Results: The mean  SD unadjusted cost was $9,112  $4,434 (range $2,001 to
$49,922). The unadjusted mean cost ranged from $12,490 in California to $4,650
in Utah, each significantly different from the mean of $8,903 in the median state,
Washington (p 0.0001). After adjusting for all potential confounders total cost
was highest in Colorado and lowest in New Jersey, which were significantly
different from the median, Washington ($10,750 and $5,899, respectively, vs
$8,641, p 0.0001). The model explained 85.9% of the variance with regional
variation accounting for the greatest incremental proportion of variance (35.1%)
and case mix variables accounting for an incremental 32.3%.
Conclusions: The total cost of radical prostatectomy varies significantly across
states. Controlling for known total cost determinants did not completely explain
these differences but altered ordinal cost relationships among states. Cost variation
suggests inefficiencies in the health care market. Additional studies are needed to
determine whether these variations in total cost translate into differences in quality
or outcome and how they may be translated into useful policy measures.
Key Words: prostatic neoplasms, prostatectomy, health policy, small-area
analysis, costs and cost analysis
PROSTATE cancer is the most commonly
diagnosed noncutaneous malignancy
in American men with approximately
186,320 incident cases in 2008.1 The
total annual national expenditure on
CaP in the United States is high with
estimates ranging between $1.72 bil-
lion2 and $4.75 billion3 annually ac-
cording to 1990 costs.4 The cost bur-
den to taxpayers is also substantial
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with $927 million spent on CaP care for Medicare
beneficiaries in 2001.5 Approximately 48% of spending
on CaP treatment is associated with inpatient care, of
which a large fraction is attributable to surgery.5
A Scandinavian randomized trial showed that RP
is superior to watchful waiting for CaP.6–8 However,
no randomized data exist on the comparative effec-
tiveness of other available therapies, such as radia-
tion or active surveillance etc.9,10 Accordingly ther-
apeutic uncertainty has led to wide variation across
American geographic areas in procedures used to
treat CaP, such as RP.11–13
However, the choice of therapy may be influenced
not only by uncertainty about oncological superiority
but also potentially by cost since patients are known to
use less health care and less expensive health care
when they are forced to pay for it out of pocket.4,14,15
Likewise providers of medical services produce less of
any service as its cost increases.16,17 Since legal and
payment mechanisms vary across states, we deter-
mined whether there is also state level variation in the
cost of RP and whether we could explain this variation
by adjusting for regional and patient level variables
associated with cost.
METHODS
We used data available in 2009 from the 2004 HCUP-NIS
(HCUP Databases. Healthcare Cost and Utilization Project
[HCUP]. August 2009. Agency for Healthcare Research and
Quality, Rockville, MD. www.hcup-us.ahrq.gov/nisoverview.
jsp.), a 20% stratified sample of discharges from community
hospitals representing the largest all payer, inpatient care
database in the United States. Additional subfiles, the
HCUP 2004 cost-to-charge ratio and hospital weights files,
were merged with the core file to determine economic costs
and hospital level covariates.
The database included data on 7,978,041 inpatient dis-
charges from 2004. Since RP can only be performed once in
any patient, we assumed that hospital discharges listing the
RP procedure code identified unique patients. We limited
data on the 3,264,088 men to the 2,171,128 who were 40
years old or older. We identified 11,254 patients with a
diagnosis of CaP (ICD-9 code 185) who underwent RP (ICD-9
procedure code 60.5). We excluded from study 1,264 patients
with missing data other than race and 17 who underwent
simultaneous cystectomy (ICD-9 procedure codes 57.6, 57.7,
57.71 or 57.79) since this would indicate CaP diagnosed
during treatment for bladder cancer. Based on analysis sug-
gesting natural breaks at the low and high ends of the TC
distribution we excluded 52 patients in whom TC was less
than $2,000 and 21 in whom TC was greater than $50,000,
leaving a final study sample of 9,917.
The primary outcome variable was TC, determined by
multiplying total charges by a hospital wide, all payer inpa-
tient cost-to-charge ratio per hospital derived from CMS
standardized hospital accounting reports. This ratio removes
differences in markup used by hospitals to account for dif-
ferences in payer mix, local competition and price strategy.18
Documentation, data and reports on cost estimation meth-
ods are available from the Agency for Healthcare Research
and Quality.
The primary independent variable was the state in
which the hospital is located. The 2004 HCUP-NIS con-
tains data from 37 states but no records from Hawaii were
available of men undergoing RP and no cost-to-charge
conversion data were available from Texas. The local area
wage index developed for CMS reimbursement accounts for
geographic variations in the price of hospital inputs endog-
enous to the local market. To allow for variable cost elasticity
with respect to input prices we used this index as an explan-
atory variable.18 Covariates were classified into 3 classes,
including patient demographics, case mix and hospital fac-
tors.
Demographics included race, urban-rural residence,
median income in the patient residential ZIP Code™ and
primary insurance payer. Race was classified as a 4-level
variable comprising race and ethnicity (white, black, other
or missing). White was the reference group. Other in-
cluded Hispanic, Asian or Pacific Islander, Native Amer-
ican or other patients. Urban-rural residence was a 4-level
variable describing county of residence, including large
metropolitan (1,000,000 or more residents), small metro-
politan (fewer than 1,000,000 residents) and micropolitan
or nonurban (reference). Quartile classification of the es-
timated median household income in the patient ZIP Code
was defined as $1 to $35,999, $36,000 to $44,999, $45,000
to $58,999, or $59,000 or greater with the lowest income
serving as the reference. Primary insurance payer was
coded as a 3-level variable, including private insurance;
Medicare or Medicaid; or self-pay, no charge or other
payer. Private insurance was the reference.
Case mix included the continuous variables age in years,
length of stay in days and number of procedures (maximum
15) as well as the 2 categorical variables alive (reference) or
dead at hospital discharge, and a comorbidity score. Using
the updated method of Elixhauser et al19 we determined the
presence or absence of ICD-9 codes corresponding to any of
29 comorbidity measures according to HCUP-NIS (HCUP
Databases. Healthcare Cost and Utilization Project [HCUP].
August 2009. Agency for Healthcare Research and Quality,
Rockville, MD. www.hcup-us.ahrq.gov/nisoverview.jsp.). They
were summed and grouped into the categories of 0, 1 to 2, or
3 or greater comorbidities. Hospital characteristics were bed
size, designated by HCUP as small, medium or large based
on the number of beds specific to the hospital location and
teaching status. Ownership/control was stratified as public,
voluntary (reference) and proprietary when a hospital and
region were sufficiently large. In smaller strata public and
private were combined with voluntary and proprietary hos-
pitals comprising an individual private category. A separate
category was created when no stratification was advisable
due to limited hospital numbers according to HCUP-NIS.
Teaching status was binary, including teaching (reference)
or nonteaching. Urban-rural location, coded as rural vs ur-
ban (reference), was defined by Core Based Statistical Area
codes.
Bivariate association between each covariate and TC
was assessed by simple linear regression for continuous
variables and ANOVA for categorical variables. Unad-
justed mean TCs were calculated for each level of the
categorical variables. The slope (change in TC per unit
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change in the independent variable) was calculated for
continuous variables.
Due to the skewed TC distribution we modeled log-
transformed TC as the dependent variable in multivari-
able models. We accounted for clustering patients in hos-
pitals using generalized estimation equation models. We
initially performed unadjusted examination of state vari-
ation in TC and then controlled sequentially for the local
area wage index, demographics, case mix and hospital
characteristics to establish incremental improvements in
model fit. Incremental fit was determined by calculating
the incremental proportion of variance, comparing frac-
tional differences in the [2]log likelihood of successive
models. All covariates were presumed to be important
confounders and were kept in the model regardless of statis-
tical significance. We performed smearing retransformation
to determine the TC per discharge, adding half the variance
of the model error to the fitted value of log TC before expo-
nentiation.20 Ordinal relationships between the TC per dis-
charge of the states were examined.
Statistical analysis was done using SAS® 9.1. We used
ArcGIS® 9.3 geographic information system software to
visualize the geographic variation of RP TC across states.
Individual state cartographic boundary files were obtained
from the United States Census Bureau.21 The mean unad-
justed RP TC per state was categorized as significantly be-
low themedian, no different from themedian or significantly
above the median and indicated on the map by shading. A
similar process was repeated to create a shaded map of the
United States for mean adjusted RP TC.
RESULTS
Mean  SD patient age was 61.0  7.0 years. Mean
unadjusted TC was $9,112 $4,434 (range $2,001 to
$49,923). Men spent an average of 2.9  1.7 days in
the hospital and underwent 2.2  0.9 procedures.
Eight men (0.1 %) died as inpatients. Of the study
sample 58% were white, 29% had no race informa-
tion available, 65% had private insurance, 48% lived
in a large metropolitan area and 31% resided in a
ZIP Code where the median annual income was
greater than $59,000. Massachusetts contributed
the greatest number of patients (685 or 7%). Of the
patients 92%, 70% and 56% were treated at urban,
large and teaching hospitals, respectively.
Unadjusted mean costs were based on simple,
untransformed linear regression or ANOVA. Wash-
ington was selected as the referent since its costs
remained at or near the median in all models. We
discovered significant unadjusted statewide varia-
tion in TC. Compared with the mean TC in Wash-
ington the highest cost state was California and the
lowest was Utah ($8,903 vs $12,490 and $4,650,
respectively, each p 0.0001). All other covariates
were significantly associated with TC except insur-
ance coverage and patient age.
The table shows the results of the unadjustedmodel
determining log-transformed TC, accounting for pa-
tients clustered at hospitals. Unadjusted means were
calculated using smearing retransformation. Adjust-
ing for covariate groups, including local area wage
index (cost of living), demographics (urban/rural resi-
dence, race, median income quartile and primary in-
surance), casemix (length of stay, patient age, number
of comorbidities, number of procedures and in-hospital
survival) and hospital characteristics (ownership, bed
size, teaching status and urban/rural location), to-
gether explained 85.9% of the variance in TC (5.6%,
4.1%, 32.3% and 8.7% incremental proportion of vari-
ance, respectively). The unadjusted model alone re-
gressing log-transformed TC on hospital state ex-
plained 35.1% of the variance.
All covariates were considered potential confounders
and included in the model, although insurance status
and agewere not significantly associatedwith TC. In the
fully adjusted model with Washington as the reference
(mean cost $8,642) the highest cost state was Colorado
and the lowest was New Jersey ($10,751 and $5,899,
respectively, each significantly different from the me-
dian, p0.0001).We then rank ordered the states by TC
Log-transformed linear regression models with
smearing retransformations
Hospital State
Unadjusted Fully Adjusted
Estimate ($) p Value Estimate ($) p Value
Colorado 10,305 0.0003 10,751 0.0001
Minnesota 12,041 0.0001 10,494 0.0001
Massachusetts 11,694 0.0001 10,403 0.0001
Virginia 10,124 0.0001 10,260 0.0001
Georgia 9,211 0.3006 10,022 0.0001
Florida 8,589 0.1256 9,638 0.0002
Vermont 10,237 0.0476 9,552 0.0737
California 11,943 0.0001 9,420 0.0063
Arkansas 7,562 0.0001 9,240 0.0621
Nebraska 10,496 0.0001 9,201 0.094
South Carolina 8,950 0.9569 9,133 0.0787
New Hampshire 11,594 0.0001 9,057 0.2838
Indiana 11,114 0.0001 9,046 0.3557
West Virginia 8,825 0.7731 9,010 0.359
Illinois 9,261 0.2808 8,995 0.1317
Tennessee 8,110 0.0003 8,988 0.1852
Kentucky 7,306 0.0001 8,863 0.4385
Michigan 9,364 0.1765 8,853 0.4202
Ohio 8,334 0.0247 8,713 0.786
Missouri 7,663 0.0001 8,669 0.9214
Washington 8,965 Referent 8,642 Referent
Oregon 9,340 0.2292 8,629 0.9558
North Carolina 7,707 0.0001 8,536 0.6392
Arizona 7,317 0.0001 8,152 0.0541
South Dakota 8,496 0.2526 8,053 0.0892
Rhode Island 9,139 0.6944 7,971 0.039
Maryland 7,697 0.0001 7,748 0.0004
New York 10,093 0.0002 7,597 0.0001
Wisconsin 7,703 0.0001 7,518 0.0001
Kansas 6,990 0.0001 7,428 0.0001
Nevada 7,745 0.0008 7,257 0.786
Iowa 6,996 0.0001 7,174 0.0001
Connecticut 8,373 0.1312 6,266 0.0001
Utah 4,733 0.0001 6,021 0.0001
New Jersey 7,572 0.0001 5,899 0.0001
REGIONAL VARIATION IN RADICAL PROSTATECTOMY COST1506
The Journal of Urology, Volume 183, Issue 4, April 2010, Pages 1504-1509
and used geographic information system mapping to
show the results of the unadjusted and fully adjusted
models (figs. 1 and 2). Adjusting for all potential con-
founders did not eliminate regional variation in TC but
altered ordinal TC relationships between several states.
DISCUSSION
Small area variations in resource input, service use
and expenditure may reflect inequalities in patient
care and uncertainty regarding treatment effective-
ness among physicians.11 CaP treatments are often
considered in such analyses since there is little ran-
domized evidence for the comparative survival ad-
vantage of 1 treatment over another.5,12,13,22 Con-
siderable effort has been expended to explain these
variations in practice, primarily focusing on the
characteristics of physicians who order higher level
care and the circumstances under which they prac-
tice.23–25 Cost is an important determinate of proce-
dure supply and demand.14–17 Despite this well rec-
ognized phenomenon, to our knowledge there are no
data on geographic variation in the cost of urological
procedures. We determined the existence of state
level variation in the cost of RP and its persistence
despite controlling for known cost determinates.
A fully adjusted model explained 85.9% of the
variance in cost but significant state level variation
in TC persisted. Hospital state explained the great-
est incremental proportion of TC variance (35.1%)
while case mix, which reflects the actual amount
and complexity of care received by an individual,
accounted for 32.3%. Other covariates, such as hos-
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Figure 1. Mean unadjusted RP TC. White areas indicate not reporting. Blue areas indicate less than $8,400 and belowmedian (p0.05).
Gray areas indicate $8,401 to $10,000 and no different than median (p 0.05). Red areas indicate greater than $10,000 and above
median (p 0.05).
Texas
Montana
Utah
California
Idaho
Nevada
Oregon
Arizona
Iowa
Michigan
Colorado
Wyoming
Kansas
Ohio
Minnesota
Illinois
New Mexico
Nebraska
Missouri
Wisconsin
Washington
Georgia
Oklahoma
Maine
South Dakota
North Dakota
New York
Virginia
Alabama
Arkansas
Louisiana
Kentucky
Tennessee North Carolina
Pennsylvania
Florida
Indiana
Mississippi
South Carolina
West VirginiaMaryland
Vermont
New Jersey
Massachusetts
New Hampshire
Connecticut
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pital characteristics, local area wage index and de-
mographics, accounted for a smaller proportion of
the variance (8.7%, 5.6% and 4.1%, respectively).
A hypothesis explaining unadjusted state level
variation in TC is that variation in RP TC simply
reflects state level variation in overall price for all
local goods and services. This theory seemed plausible
initially since northeastern and western states with
well-known high costs of living were also those with
the highest mean TC (fig. 1). However, controlling for
the local area wage index accounted for only 2.7% of
the variance in TC and did not alter the significance of
the TC variation among states, suggesting it was not
cost of living driving this phenomenon.
Adjusting for covariates associatedwith cost altered
the ordinal relationship of TC between states. While
some states retained their position relative to the me-
dian after adjustment, ie California had a high and
New Jersey had low a TC before and after adjustment,
other states changed in rank order. Adjustment
tended tomove southeastern andmidwestern states to
higher cost positions while northeastern states tended
to move lower. The most dramatic example was New
York, which had one of the highest TCs on unadjusted
analysis but one of the lowest after adjustment.
There are several potential explanations for this
phenomenon. States with higher unadjusted costs,
which also tend to have a higher cost of living, may
be under greater scrutiny from payers, as reported
for individual hospitals with outlier payments to
CMS and with anesthesia departments that use
costly drugs.26,27 Such administrative scrutiny may
force high cost providers to lower costs and operate
under narrower margins. States with lower unad-
justed costs may escape such pressure. Another pos-
sible explanation is that regions with higher prices
may have higher population densities and treat
more patients for all conditions. Higher statewide
clinical volume may lead to economies of scale whose
cost savings would only be appreciated after per-
forming a fully adjusted analysis.
Our study has several limitations, including its cross-
sectional design, making it impossible to establish cau-
sality. We could not assess more specific details of care
and complexity within individuals, whichmay better ex-
plain TC. This may be particularly important if there is
regional variation in the stage at which CaP is diag-
nosed. Furthermore, NIS does not include outpatient
data, precluding cost comparison between surgery and
radiation therapy. Nor could we assess the rate of com-
plications or the quality of care delivered.
Despite these limitations our analysis has a num-
ber of strengths. Data were derived from a nation-
ally representative database including all types of
patients and providers. Most regional variation data
are based exclusively on CMS claims but our study
benefits from including all payer data, allowing us to
avoid the controversy associated with conclusions
based only on CMS data.28 Most importantly NIS pro-
vides accurate data on the economic cost of therapy
rather than the accounting cost or patient charge, al-
lowing inferences to be made on the regional variation
in resource consumption associated with RP without
confounding from varying insurance reimbursement
or other payment related factors.29
Perhaps the most important conclusion from these
data is the caveat that unadjusted mean costs may be
misleading. With almost 60,000 RPs performed in
2000 and the number continuing to grow, an effort to
decrease cost and/or improve quality could have an
important impact on CaP care in the United States.5
The optimal targets for large-scale policy reform may
not be the groups that appear to have the highest cost
at first glance. A policy which simply cuts federal fund-
ing to a high cost state may backfire if that state is
actually a low cost provider on adjusted analysis. In
the debate over health care reform careful analysis of
all factors contributing to TC is imperative. Without it
wemay unwittingly jeopardize access to and quality of
care for many patients.
CONCLUSIONS
The RP TC varies significantly across states. Control-
ling for known determinants of medical care costs did
not completely explain these differences but altered
ordinal cost relationships between several states in
informative ways. Differences in cost suggest ineffi-
ciency in the various health care markets. Additional
studies are needed to determine whether these re-
gional variations in TC translate into differences in
quality of care or patient outcomes and how they may
be translated into useful policy measures.
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EDITORIAL COMMENT
In industry a hallmark of good quality is minimal
variation in the production process. These authors
studied the production of RP. Their analysis shows
wide variation in costs despite adjusting for medical
case mix and local labor markets. Their analysis is
based on data from 2004, a period preceding the
widespread adoption of robotic prostatectomy.
Health care costs are a growing political issue. Phy-
sicians have historically defended the high cost of
American health care by claiming the highest quality
in the world. That does not explain the wide varia-
tions noted by these authors. Responsible health
care reform requires urologists to participate in the
development of care pathways that minimize re-
source consumption and collect better data on short-
term and long-term outcomes.1 We can defend cost
differences based on case mix and better quality but
not based on inefficient, inappropriate or just more
expensive practices.
Peter C. Albertsen
University of Connecticut Health Center
Farmington, Connecticut
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